跳至主要内容
临床试验/EUCTR2008-007483-42-DE
EUCTR2008-007483-42-DE进行中(未招募)不适用

A 24-Week, Flexible-Dose, Open-label Extension Study of Lurasidone for the Treatment of Bipolar I Depression

Sunovion Pharmaceuticals Inc0 个研究点目标入组 651 人开始时间: 2009年8月31日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
651

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Subject has agreed to participate by providing written informed consent
  • Subject has completed 6 weeks of treatment in Study D1050235, D1050236 or
  • Subject is judged by the investigator to be suitable for participation in a clinical trial
  • involving open-label lurasidone treatment and is able to comply with the protocol in the opinion of the investigator
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Subject scores = 4 on MADRS item number 10 (suicidal thoughts) at baseline (Day 42 in Studies D1050235, D1050236 or D1050292)
  • Subject is considered by the investigator to be at imminent risk of suicide or injury to self, others, or property

研究者

相似试验

A 24-Week, Flexible-Dose, Open-label Extension Study... | 临床试验